MedPath

ATROPINE SULFATE

ATROPINE SULFATE INJECTION, USP 1mg/mL

Approved
Approval ID

0060b971-19bd-2849-e063-6294a90afca8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 28, 2024

Manufacturers
FDA

HF Acquisition Co LLC, DBA HealthFirst

DUNS: 045657305

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ATROPINE SULFATE

PRODUCT DETAILS

NDC Product Code51662-1626
Application NumberANDA216120
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateJanuary 28, 2024
Generic NameATROPINE SULFATE

INGREDIENTS (5)

SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCF
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
ATROPINE SULFATEActive
Quantity: 1 mg in 1 mL
Code: 03J5ZE7KA5
Classification: ACTIB
© Copyright 2025. All Rights Reserved by MedPath
ATROPINE SULFATE - FDA Approval | MedPath